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ABSTRACT: In 1995, the Global Initiative for Asthma (GINA) published an evidence-based
workshop report as a guide to clinicians managing asthma patients, and has updated it annually
to ensure that recommendations remain current. Although the report has been widely
disseminated and influenced clinical practice and research, its major objective, of forming the
basis for local and national initiatives to improve services for asthma patients, remains to be
achieved. Over recent years, the science of guideline implementation has progressed, and
encouraging examples of successful asthma programmes have been published. This report is
intended to draw on this experience and assist with the translation of asthma guideline
recommendations into quality programmes for patients with asthma using current knowledge
translation principles. It also provides examples of successful initiatives in various
socioeconomic settings.
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W
orldwide, significant ‘‘care gaps’’, de-
fined as discrepancies between optimal
and provided care, still exist for the
management of major chronic diseases, including
asthma and chronic obstructive pulmonary disease
(COPD) [1, 2]. The provision of evidence-based
guidelines has helped guide optimal disease man-
agement and clinical practice guidelines (CPGs)
have been developed for most conditions [3, 4].
Moreover, experience over two decades has also
resulted in considerable modification and improve-
ment in the methodology for their development.
Quality standards have been suggested for the
development of these guidelines, such as those
stated in the AGREE (Appraisal of Guidelines for
Research and Evaluation) tool and recent reports
[5–8]. Furthermore, grading of the evidence has
improved and tools such as the Grades of Recom-
mendation, Assessment, Development and Evalua-
tion (GRADE) system is being increasingly used by
national and international societies, including the
World Health Organization [9]. GRADE is con-
sidered by many as the best option to grade
evidence in the production of current clinical
practice guidelines, making it possible to bring
the scientific evidence closer to real life and clinical
practice. It provides a systematic and transparent
framework that helps to clarify questions, deter-
mine the outcomes of interest, and summarise the
evidence that addresses a question (GRADE work-
ing group, www.gradeworkinggroup.org).
However, even the best guidelines, if not ade-
quately disseminated and implemented, will not
influence patient care. It is obvious that, at best, the
adoption and implementation of asthma guidelines
is patchy. This is attributable to a large number of
barriers, both at the programme level and due to the
behaviour and habits of patients and physicians
[1, 10–12]. As reviewed by BAIARDINI et al. [13],
guidelines implementation is a complex process
that is influenced by different factors, including the
characteristics of guidelines, the social, organisa-
tional, economic and political context, and by
implementation strategies. Patient’s and physician’s
guideline implementation of recommendations are
influenced by their knowledge, attitudes, skills,
experiences, beliefs and values.
Fortunately, these issues have been considered and
the science of guideline development has been
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accompanied by the development of methodologies and tools to
facilitate the uptake of guideline recommendations and to
translate them into concrete actions. While these are better known
to health systems experts, their importance is less well appreciated
by practicing clinicians. Since narrowing the care gap involves
both the organisation of health services and individual best
practice, a co-ordinated, comprehensive and carefully planned
approach is required, involving all players in the provision of
healthcare [14–17]. Although lack of financial resources is often
cited as the limitation to implementing improved care, the
experience of many local and national initiatives is that quality
improvements may be achieved with little or no additional
financial cost (savings have even been reported) as cost shifting,
principally from expenditure on acute services to effective chronic
disease management, forms the basis of the strategy. Ideally, the
quality improvement programme should involve dissemination
of customised best practice guidelines, an implementation
strategy and an evaluation plan to assess its impact and guide
further programme improvements.
The need for these three components is not widely appreciated
by those who, with good intentions, develop clinical practice
guidelines. In a survey of 2,341 guideline developers who
submitted their guidelines to the Canadian Medical Association
Infobase between 1994 and 2005 (1,664 (71%) surveys returned),
although there had been improvements in guideline develop-
ment methodology, developers were more likely to report using
computerised search strategies (94% versus 88%), publish the
search strategy (42% versus 34%), reach consensus using open
discussion (95% versus 78%), and evaluate the effectiveness of the
dissemination strategies (12% versus 6%) for the periods 1994–
1999 versus 2000–2005; dissemination and implementation
activities appeared to have decreased, as had the study of the
impact of the guidelines on health outcomes (24% versus 5%) [18].
Guideline dissemination is the easiest of the three components,
but may be the least effective. It is usually achieved through
medical/scientific publications, mailings, continuing profes-
sional development, workshops, symposia and, increasingly,
innovative internet-based programmes. Formal evaluation of the
effectiveness of these methods confirms that some of the most
widely practiced methods, such as lectures and distribution of
guidelines, are ineffective or insufficient to change the behaviour
of carers, particularly physicians. More complex interventions
employing social marketing techniques are more successful, but
form only part of successful strategies [17, 19].
Educational meetings alone do not seem to be effective in changing
complex behaviour patterns amongst physicians [20]. GRIMSHAW et
al. [21] reported a systematic review of the effectiveness and cost of
different guidelines development, dissemination and implementa-
tion strategies. The authors concluded that there remains an
imperfect evidence base as to which strategy is best, and that many
factors need to be considered. For example, implementers should
select a clinical need that is most likely to be responsive to an
intervention, and has potential for improving behaviour. An
assessment of barriers and facilitators of the intervention and its
probable cost-benefit is essential. Readers are advised to consult
some of the published literature on this topic [22–26].
Guideline implementation requires specific interventions tailored
to different healthcare systems and settings, taking into account
available human and material resources. Knowledge translation
models have been developed to help ‘‘operationalise’’ the
integration of evidence provided through guideline recommen-
dations or other means of knowledge synthesis, e.g. Cochrane
meta-analyses, web-based repositories and other forms of
knowledge synthesis, into care, such as the ‘‘Knowledge-to-
Action’’ framework developed by GRAHAM et al. [27] (fig. 1).
Furthermore, tools to assess ‘‘implementability’’ of a guideline
(e.g. the GuideLine Implementability Appraisal (GLIA) tool) have
become available and can be useful to evaluate how a particular
guideline is translatable into care [28].
The purpose of this review is to provide some basic principles for
practice guidelines implementation and outline the steps
required, as well as examples of such initiatives in various
socioeconomic settings. It is based on the current literature on
CPG implementation and the experience of colleagues involved
in the Global Initiative for Asthma (GINA). It is hoped that this
will provide assistance to those considering local or national
implementation of CPGs, particularly the GINA Strategy for
Diagnosis and Management of Asthma.
PLANNING A GUIDELINE IMPLEMENTATION
PROGRAMME
The steps involved in the development of a guideline implemen-
tation programme are shown in table 1. Although listed in the
order in which they might be addressed, this can be amended
according to local conditions. The programme described is for a
national or regional initiative, but most steps need to be applied in
smaller scale initiatives within practices, clinics and hospitals.
Identify stakeholders and form a working group
Stakeholders at national or local level should be identified
and invited to participate, including public health authorities,
government representatives, non-governmental organisations
(NGOs), respiratory and allergy societies, patient organisations,
etc. The motivation behind each participant’s involvement should
be determined to ensure that these are addressed and, as far as
possible, met. Strategies should be considered to motivate other
partners to become involved in the initiative.
Then, a working group should be developed. In some countries,
this has been done under the auspices of, or in collaboration with,
the national leadership of the Global Alliance against Chronic
Respiratory Diseases [29], a scientific society, a group devoted to
respiratory care or a local or national health authority. The
intention should be, where possible, to ensure that the plan for
asthma care is adopted by and becomes embedded in the
activities of health services in a local region or national health
authority. This is usually best achieved when health authorities
become full members of the initiative and at an early stage of the
process. The working group should include a mix of specialists/
opinion leaders in the management of asthma, primary care
physicians and general practitioners, nurses, pharmacists, health
educators and patients with asthma. Ideally, specialists in
implementation methodology and communications should also
be involved. It should be remembered that enduring and
productive collaborations are more likely when partners are
involved from the start, rather than when they are invited later.
Once an implementation plan has been developed participants
should agree on milestones, and then allocate specific tasks to
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members to ensure that the work is completed within a realistic
timeframe. It is usually best to develop the plan around existing
structures and interested groups. Ideally a project co-ordinator
should be hired to supervise the various aspects of the initiative.
Select the guideline to be implemented and whether it
requires adaptation
Before disseminating or attempting to implement guidelines they
must be adapted for use in the intended practice setting. This
should be done by local experts, but more sophisticated
instruments, such as ADAPTE [30], have been developed in
recent years to provide a framework for this task. This method
involves a series of steps, including: 1) the planning and set-up;
2) the adaptation process; and 3) the development of a final
document. Although this require resources and expertise, in
many instances it serves as a valuable exercise to sensitise the
team to local realities and results in a more implementable
management and treatment guideline.
Perform a needs assessment and review of current status of
care and main care gaps
The most up-to-date statistics on asthma morbidity, mortality
and healthcare use in the target area, including hospital
admissions, should be collected. The most useful of these are
statistics on hospitalisations and emergency room visits for
asthma, as proposed in the recently launched GINA 5-Year
Asthma Control Challenge [31].
Next to consider is whether there is a comprehensive review of
current practices and resources available for the care of patients
with asthma. This should involve points of care (public and
private sector), referral patterns (including use of acute care
facilities and hospitals), availability and accessibility of asthma
drugs, organisation of health services, training of health carers
and practitioners, treatment policies and practices, and many
other facts.
This analysis will enable the identification of barriers of
implementation. Barriers to optimal care, [32, 33], include
external barriers that limit the ability to perform the recom-
mended action, such as those related to patients, guidelines or
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FIGURE 1. The ‘‘Knowledge-to-Action’’ framework. Adapted from [27].
TABLE 1 A plan for a guideline implementation programme
1. Identify stakeholders and form a working group
2. Select the guideline to be implemented and determine whether it needs
adaptation
3. Perform a needs assessment and review current status of care and main
care gaps
4. Select the main care gaps to be addressed and key messages to convey
5. Develop and prioritise implementation strategies
6. Develop and agree on specific indicators of change and targets for each
outcome in the initiative
7. Ensure that the resources required are available
8. Produce a step-by-step implementation plan
9. Plan initial interventions and evaluate their effects
10. Review the project in light of pilot projects and other information gathered
11. Determine how the current interventions could be improved/evaluate the
feasibility of implementing the project
12. Plan continuation/expansion of the initiative and its long-term evaluation:
ensure long-term planning
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environmental factors, and internal barriers that limit adherence.
The latter include prevailing knowledge gaps, beliefs and
attitudes. Barriers relating to both caregivers and to patients
should be considered.
Select the main care gaps to be addressed and key
messages to convey
A list of common asthma management care gaps is shown in
table 2. Care gaps should be ranked in terms of the size and their
effect upon the morbidity and/or mortality. The reasons for gaps
should be sought and considered in planning strategies for
addressing them. Finally, the strategy for educating carers and
patients must be developed. The most important gaps must be
prioritised and a limited number (three or four) selected for social
marketing. Social marketing is defined as the systematic application
of marketing to achieve specific behavioural goals for social good.
The messages must be few, simple, clear and practical. The
language and emphasis must be tailored to the group to whom
they are addressed. For example, for health professionals a message
might be that: ‘‘a child that coughs at night in the absence of a cold
may have asthma’’; ‘‘inhaled corticosteroid is the treatment of
choice for persons with persistent asthma symptoms’’; and
‘‘persistent symptoms of bronchitis after an upper respiratory tract
infection indicates a need for intensified controller treatment for
asthma’’. For patients and parents, ‘‘asthma attacks do not routinely
require antibiotics’’.
Develop and prioritise implementation strategies
A review of experience in other countries or practice environ-
ments similar to that being considered will provide useful clues
TABLE 2 Common asthma management care gaps#
Management care gap Example of barriers to reduce
the gap
Possible implementation
strategy
Process and outcome
measures
Over/underdiagnosis/lack of early
recognition of asthma
Unavailability of pulmonary
function tests
Identification of nearby pulmonary
function test facilities
Percentage of patients in
whom pulmonary function
tests are performed
Not considering asthma when symptoms
present
Increase awareness Increase awareness Prevalence of new asthma
diagnoses
Physician’s non-adherence to guidelines Insufficient knowledge/motivation
to implement guideline
Improved dissemination/
interactive workshops
Assessment of recommendations
implementation into care
Patient–doctor communication Insufficient time/communication
skills
System changes: asthma
educator referral
Degree of patient satisfaction
with communication
Inadequate assessment of asthma control Lack of knowledge of criteria Education/CME Survey of criteria use
Insufficient environmental/
preventative measures
Lack of time to explain Increase access to educator
Involve patients as educators
Survey implementation of
intervention
Lack of individualised
pharmacotherapy
Insufficient knowledge
of guideline
Education/CME Assessment of treatment
(e.g. audit)
Lack of education and guided
self-management
Unavailability of educators Increase access to educator
Involve patients as educators
in the process
Percentage of patients offered
education
Absence or no use of an action plan
for the management of exacerbations
Not enough time to produce
and explain
Increase access to educator, involve
patients as educators in the process
Provide simple printed formats
for clinicians
Number of patients receiving
a written
action plan
No assessment of techniques (inhalers,
peak flow measurement)
Lack of time or knowledge Systematic assessment at visits Percentage of patients in whom
this is checked
No assessment of adherence to therapy Not integrated to practice Reminders Percentage of patients in whom
this is checked
No regular follow-up: discontinuity of care Lack of follow-up arrangements Improved management Survey on regular follow-up
Inadequate management of acute asthma Inadequate management Adherence to guidelines Improve ED staff
training/asthma management
Regular survey of hospital
admissions and deaths
Variable/insufficient access to care: non-
availability of asthma controllers
Insufficient resources Increase resources: revise process Assess continuity of care
Poor communication between various
groups of health care personnel
Lack of willingness to change Organise joint sessions on
asthma care
Focus group assessing this
aspect of care
CME: continuing medical education; ED: emergency department. #: for some of these care gaps, more evidence on the effectiveness of implementation strategies is
required; however, the recommendations provided are based on current recommendations.
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to successful interventions and approaches. Examples of these are
provided as resources on the GINA website (www.ginasthma.
org).
Prioritisation of strategies could be based on their ability to
address identified barriers and to leverage identified facilitators in
a specific context. Evaluating the evidence about the effectiveness
of the strategy is also important. The Cochrane Effective Practice
and Organization of Care Group (EPOC) publications are a useful
reference for checking the effectiveness of proposed interventions
[34]. It should be remembered that quality of care improvements
are generally made in small steps that address critical barriers
rather than through broad-ranging changes.
For example, all of the following have been shown to improve
asthma outcomes: increasing access to controller drugs (inhaled
corticosteroids); encouraging the performance of spirometry;
improving the recognition and diagnosis of asthma; increasing
awareness of the need to assess asthma control; encouraging use
of written action plans; and providing asthma education [35–39].
It is wise for the working group to first select interventions that
it considers will have the greatest societal impact, such as
improving access to inhaled corticosteroids in children, especially
those with a recent hospital admission [40], as this serves as
encouragement to all involved and is likely to attract the attention
of health authorities.
Finally, patients ‘‘at risk’’ should be targeted. These include
patients with frequent exacerbations and/or highest morbidity,
those with poor adherence to treatment and follow-up, and those
with psychosocial and economic problems [41]. Teenagers and
elderly patients are also ‘‘at-risk’’ groups [42, 43].
Among the most effective methods are: reminders, ideally at the
site of care; interactive workshops; audit and feedback; and
multifaceted interventions combining two or more methods, such
as audit and feedback, reminders, local consensus processes or
social marketing [38, 44–46].
Develop and agree on specific indicators of change and
targets for each outcome in the initiative
Medical audit has been used to improve both the process and the
quality of care for patients. The process involves setting standards,
measuring current care against those standards, identifying gaps
between the standards and the achievement of these, and finally,
following up the performance of new interventions in terms of
these standards. This process serves both as a stimulus to change
and as a means of educating health professionals on best
guideline-based practice [21, 37, 47–49]. Live, dynamic audit can
be used to provide data, with immediate feedback for partici-
pants, as a motivator for change. In one such example (available at
www.guideline-audit.com), physicians audited their care of
patients with COPD and chest infections, and the diagnosis,
acute management and assessment of control of patients with
asthma and were able to compare their management performance
with that of others and standard benchmarks.
An integral part of guideline implementation is the selection of
realistic targets and key indicators to determine if these have been
achieved. Ideally, a main goal and a selection of secondary
objectives should be identified. The most relevant outcomes to be
measured and what levels of change should be achieved should
be decided (table 3). Furthermore, milestones for evaluating the
interventions should be established with specific proposals for
the type of action to be considered if the targets are not achieved.
Ensure that the resources required are available
It is essential to determine the resources and funding that will be
required to support the initiative, and to assess whether they
are available. Funding can be obtained from various sources,
including national funds, funding agencies (for implementation
research), medical or scientific societies, and industry partners.
Produce a step-by-step implementation plan
The implementation plan should involve an initial intervention or
a series of pilot projects that provide the basis for the final plan
and its expansion and scale-up in the target region. Long-term
sustainability must be a primary objective of any plan.
It is usually wise to begin on a small scale with a limited number
of people, and select an initial intervention that has a good chance
of success, as this will motivate the group. It is also important to
initially select a targeted group who express interest in seeing the
plan implemented. The importance of buy-in was illustrated by
SHEEHAN [50] who reported that while only 53% of those stating
their intention to implement an action did so, in those expressing
reluctance only, 3% became involved. Furthermore, choosing a
medium-range time schedule (e.g. 3 months) will allow rapid
assessment of early results. The initiative should then be
reviewed in light of the initial pilot projects and other information
gathered to determine whether and how the strategy should be
continued or improved, and if it is sustainable with the current
available resources and level of commitment from the planning
group and other parties.
The outcome of interventions should be assessed according to the
pre-determined indicators, and barriers and facilitators should be
reviewed on a regular basis. The monitoring/evaluation pro-
cesses must capture unintended outcomes or impacts, as well as
expected ones (or ones of interest). Other aspects of the project,
such as cost–benefit, reduction of morbidity outcomes, healthcare
use, etc. (table 3), are important in making decisions on long-term
goals and refinement of strategies. Successes should be pub-
licised; a useful format is to describe successes around individual
cases and personal experiences.
TABLE 3 Examples of outcomes to assess the burden of
asthma and implementation
Patients
Asthma control (according to validated tools)
Asthma patients’ quality of life
Adherence to treatment
Satisfaction with treatment
Providers
Satisfaction with the guideline
Use of the guideline in current care
System outcomes
Hospital admissions for asthma (number, hospital days)
Emergency department visits
Unscheduled visits to physicians for worsening asthma
Economic outcomes (cost savings for payee and patients; direct
and indirect costs)
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Ensure long-term planning
Continuation and expansion of the initiative and its long-term
evaluation process should then be decided. It should be determined
how the intervention will be sustained, who will be charged with
the task of ensuring its continuation, and how continuing financial
and organisational support will be provided. Regular communica-
tions on the project’s impact on current care will help to sustain
interest and provision of resources for the project.
USE OF KNOWLEDGE TRANSLATION THEORIES IN
DEVELOPING IMPLEMENTATION PLANS
Knowledge translation initiatives should be based on sound
behavioural and educational theories and evidence-based strate-
gies, such as those described in the Cochrane EPOC Group [34]. A
more recent model developed in Canada is the Knowledge-to-
Action conceptual framework developed by GRAHAM et al. [27],
which builds upon commonalities found in an assessment of
planned action theories (fig. 1). The Knowledge-to-Action frame-
work involves three phases.
In the planning phase, selected guideline recommendations are
prioritised. Once the targeted population and settings have been
selected, the key messages and main outcomes of measurement
to evaluate how implementation is successful are decided, as well
as the actions to be taken.
In the assessment phase, current status of implementation and
uptake by the target audience are evaluated, as well as the impact
of the intervention and its sustainability of the imple-
mentation intervention. The intervention should be tailored,
and the strategy selected according to the targeted population; it
should identify potential barriers to implementation.
Finally, uptake by the targeted population and selected outcomes
should be monitored for impact and sustainability. The action
cycle allows interventions to be improved upon by building on
successes and learning from failures, in addition to reassessing
and addressing barriers and facilitator’s overtime. The impact of
the intervention should, therefore, be adequately evaluated at the
patient, provider and system levels.
NEW METHODS OF GUIDELINE DISSEMINATION IN
SUPPORT OF IMPLEMENTATION PLANS
New communication tools, such as the Internet, smartphones and
hand-held computers, offer innovative ways of communicating
guideline recommendations [51]. Web-based programmes, social
networking and other means of interacting (e.g. communities of
practice) are being increasingly used for guidelines dissemination
and translation [52, 53]. Embedding guidelines into electronic
health records is a novel way of improving access to treatment
recommendations at the site of care [24]. Further research is
required to determine the effectiveness of these methods.
STRATEGY PROPOSED WITHIN THE CONTEXT OF GINA
One of the major goals of GINA is to disseminate proven
methodologies for implementing asthma guidelines and, in
particular, the GINA Global Strategy for Asthma Management
and Prevention report [54]. Those interested in being more
aligned with this goal may wish to consider becoming a GINA
country initiator. A GINA country initiator is a person or an
organisation that is prepared to initiate the process of forming a
national or local task team. The initiator is given the endorsement
of the GINA Dissemination and Implementation Committee and
becomes a member of the GINA Assembly. This position ensures
that the initiator receives encouragement from GINA and has the
opportunity to present their programme and progress to GINA
for comment and advice.
Potential partners in GINA strategy implementation initiatives
could be identified within a ministry of health, such as:
programme managers and technical staff from specific pro-
grammes on chronic respiratory diseases; programme managers
and technical staff from supporting programmes, services, and
departments such as the human resources development depart-
ment, the health statistics department, the health finance
department, the drug control department, the health education
programme, the health care reforms unit, and the environmental
health unit. They may also be from outside the ministry of health,
for example: related ministries (education, science and technol-
ogy, social welfare, sport and leisure, labour, industry and
environment); chronic respiratory diseases experts; knowledge
translation experts; public health experts from academic and
training faculties; representatives from professional associations,
scientific societies (medical, pharmacists, physiotherapists and
nursing) and patient groups; local and international NGOs;
representatives from the educational sector; potential partners
who provide technical and financial support, such as multilateral
and bilateral agencies; and representatives from the community,
churches and religious leaders, the private sector and the media.
EXAMPLES OF SUCCESSFUL ASTHMA GUIDELINE
IMPLEMENTATION INITIATIVES
The examples provided below illustrate the processes described
above, and in particular the various stages of the Knowledge-to-
Action framework (fig. 1).
Finland
A multidisciplinary national asthma programme included
strategies for prevention and treatment, but also an operational
plan for their dissemination and implementation [54–59].
Effective strategies involve multiple methods, decision support
systems and interactive education. In Finland, state officials,
representatives of patient organisations, nurses, pharmacists and
general practitioners took part in the steering group of the
programme. They created a network of asthma responsible
contact persons in local health centres, as well as regional
treatment action plans. This network included as many nurses as
doctors but also pharmacists in almost every pharmacy in
Finland. The contact persons coordinated the local work, but did
not personally take care of all asthmatics. The network was kept
motivated by continuous educational activities, which had a
high rate of participation. The organisational key to success was
to emphasise the role of general practitioners in addition to
specialist care.
The asthma-specific key for treatment improvement was the
strong message to detect asthma early and start anti-inflamma-
tory medication immediately after diagnosis, i.e. "hit early and hit
hard". The idea was to take control of asthma by using a step-
down rather than a step-up strategy. Once control was achieved,
the minimum medication to maintain control was titrated during
3–6 months. To prevent asthma attacks and worsening asthma,
especially during respiratory infections, guided self-management
was effectively implemented. The patient was taught by the
general practitioner or nurse to increase the inhaled medication
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instantly if signs of symptom increase appeared. The patients also
had corticosteroid tablets at home and instructions on how to
start the course themselves if intensified inhalation therapy did
not improve control within a few days.
The extra costs of planning and implementing the programme
were small, mainly as most of the activities were carried out as part
of the routine work of the clinicians and administrators. From 1994
to 2000 the number of asthma medication users for persistent
disease in Finland increased by 42%, and detection and treatment
of asthmatic symptoms in the population improved. The major
increase (75%) in the use of inhaled corticosteroids was a direct
consequence of the programme which promoted their introduc-
tion as first-line therapy. The savings of total asthma costs (hospital
days, out-patient visits, medication, disability and loss of produc-
tion) were significant, from J300 million to almost J500 million
(minimum or maximum scenario) in one year, 2005 [60].
Brazil
Many programmes have been developed in Brazilian cities in the
last decade [61–64]. The Program for Control of Asthma (ProAR)
was developed in 2003 in Salvador, prioritising the control of
severe asthma. By facilitating referrals from the public health
system and providing proper multidisciplinary, but simple,
management including education and medication for free,
ProAR enrolled .4,000 patients with severe asthma in four
reference clinics. The patients are offered regular follow-up and
discharged back to primary healthcare only when asthma control
can be maintained without requirement of a combination of an
inhaled corticosteroid and a long-acting b2-agonist. This interven-
tion was associated with a steep decline in health resource
utilisation and remarkably reduced the rate of hospital admissions
due to asthma in the entire 2.8 million city habitants by 74% in
3 yrs [59]. Cost analysis demonstrated that this intervention was
very cost-effective and provided a financial relief to the families
and the government [62, 63]. Various other programmes have
been developed in large Brazilian cities or smaller towns with
favourable results, such as the intervention reported in Itabira [64].
South Africa
In South Africa, the management of asthma and other chronic
diseases in the public health sector has, to some extent, been
eclipsed by the demands of treating large numbers of patients
with tuberculosis and HIV infection. Researchers in South Africa
have developed and, over the course of several years, achieved
the nationwide rollout of a programme that includes asthma in
the component of comprehensive primary care offered for all
common respiratory diseases, including COPD, tuberculosis and
other infections. This programme is based on the Practical
Approach to Lung Health (PAL), developed by the World Health
Organization. PALSA Plus, as it is termed in South Africa, is a
locally customised, integrated, algorithm-based diagnostic and
management tool for use by nurses and front-line doctors in
primary care clinics. It has improved the recognition of and
ensured resourcing for the management of asthma in these
facilities. The intervention comprises a practical high-quality
manual (guideline) containing details of diagnosis and manage-
ment of asthma (updated annually) and educational aids
developed using latest knowledge translation methodology.
Educational outreach is performed using social marketing
techniques and audit forms a part of the programme. To date,
.13,000 nurses have received training in the methods and initial
results from field research confirm improvements in care,
including increased prescriptions of inhaled corticosteroids [65,
66]. The impact of this programme on mortality and hospitalisa-
tions remains to be confirmed.
Ireland
Irish asthma guidelines published in 2000 were based on the
GINA international asthma management strategy [67]. In a
survey of 400 patients with current asthma over the previous
year, 27% reported having had either an emergency visit to the
hospital or their general practitioner, 7% had been hospitalised
for asthma, 19% had sleep disturbance at least once a week, and
29% missed work or school. The level of asthma control and
asthma management in Ireland still falls short of recommended
national and international asthma guidelines and initiatives to
address this problem have been developed with the full support
of the national department of health.
Canada
The impact of asthma guidelines not only on asthma care but also
broader policy issues has been reviewed [68]. There are emerging
models of improved management of chronic disease with
targeted funding to improve physicians adherence to guideline-
based care. In British Columbia, the number of hospitalisations
for acute asthma has fallen from .3,000 annually to ,1,000
between 2003 and 2007 (H. Platts, Ministry of Health, British
Columbia, Canada; personal communication). In addition, in the
context of multicultural societies, the impact of health literacy and
ethnicity has been emphasised [69].
In the province of Quebec, Towards Excellence in Asthma
Management (TEAM) was a four-phase disease management
programme of the Quebec Asthma Education Network (QAEN)
to be carried out over an 8-yr period [70]. It included: 1) the
determination of current asthma-associated morbidity and
mortality in various Quebec regions using population maps;
2) analysis of the burden of asthma, taking into account the
socioeconomic consequences of the disease and the quality of
life of the patients; 3) comparing current medical practices with
the Canadian Asthma Consensus Guidelines for adult and
paediatric populations; and 4) determining patient’s adherence
with medical treatment and with the environmental change
recommendations. Key observations from this programme
included: the identification of specific patterns of non-adherence
in the use of inhaled corticosteroids; a lack of progress in
increasing access to spirometry in asthma education centres in
order to detect new cases; an increase in the number of referrals to
an asthma educator; improvement in the ability of nurses to
provide asthma education using an asthma hotline telephone
service; and the beneficial effects of practice tools aimed at
facilitating the assessment of asthma control and treatment needs
by general practitioners. This programme has informed continu-
ing efforts to improve guideline implementation.
Other countries
In a review of efforts to implement asthma guidelines in
developing countries, AI¨T-KHALED et al. [71] evaluated 456
consecutive patients from Algeria, Guinea, Ivory Coast, Kenya,
Mali, Morocco, Syria, Turkey and Vietnam. Overall, in 58% of
patients surveyed, the diagnosis of asthma had been confirmed
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using recognised criteria. Agreement between the practitioner
and the guidelines in assigning a grade of severity was moderate.
Practitioners tended to underestimate the severity of asthma.
Agreement between the practitioners’ assessment of severity and
treatment with inhaled corticosteroids was poor and inhaled
corticosteroids were underutilised.
THE FUTURE OF GUIDELINES IMPLEMENTATION
Much remains to be done with regard to guidelines implementa-
tion. The basic principles of guideline implementation are well
established, but unfortunately, resources continue to be wasted
on ineffective methods [16, 17, 19] (table 4). It is important that
both effective and ineffective attempts to implement asthma
guidelines be reported so that others can learn from these
experiences. Joint international efforts, for example through the
Guidelines International Network, provide a forum for guideline
implementers to exchange ideas on effective methods for
overcoming barriers to knowledge translation, and access tools
to produce better and more ‘‘translatable’’ guidelines. It is
probable that new means of communication, such as computer-
based programmes or exchanges through the Internet, will be
used [72].
CONCLUSIONS
Evidence-based guidelines are intended to provide best practice
advice, but the science of implementing them has lagged behind.
Knowledge translation techniques have been developed and
there are encouraging examples of their use in several countries.
Although conditions may vary in different practice settings, a
common set of principles for successful guideline adaptation and
implementation are now available, are gaining wider use and
their effectiveness has been confirmed, even in resource-poor
settings. Given the continued increase in asthma prevalence in
most countries and the continuing care gaps identified in almost
all, GINA, together with other members of the medical
community involved in asthma care, should see implementation
as the most urgent priority if progress is to be made in addressing
this treatable condition.
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